BACKGROUND: A Guam variant of amyotrophic lateral sclerosis (ALS-G) and parkinsonism dementia complex (PDC-G) are found in the Chamorro people of Guam. Both disorders have overlapping neuropathologic findings, with neurofibrillary tangles in spinal cord and brain. The cause of ALS-G-PDC-G is unknown, although inheritance and environment appear important. Because neurofibrillary tangles containing tau protein are present in ALS-G-PDC-G, and because mutations in the tau gene (TAU) cause autosomal dominant frontotemporal dementia, TAU was examined as a candidate gene for ALS-G-PDC-G. METHODS: TAU was evaluated by DNA sequence analysis in subjects with ALS-G-PDC-G, by linkage analysis of TAU polymorphisms in an extended pedigree from the village of Umatac, and by evaluation of linkage disequilibrium with polymorphic markers flanking and within TAU. RESULTS: Linkage disequilibrium between ALS-G-PDC-G and the TAU polymorphism CA3662 was observed. For this 2-allele system, PDC and ALS cases were significantly less likely than Guamanian controls to have the 1 allele (4.9% and 2% vs 11.5%, respectively; Fisher exact P =.007). DNA sequence analysis of TAU coding regions did not demonstrate a mutation responsible for ALS-G-PDC-G. Analysis of TAU genotypes in an extended pedigree of subjects from Umatac showed obligate recombinants between TAU and ALS-G-PDC-G. Linkage analysis of the Umatac pedigree indicates that TAU is not the major gene for ALS-G-PDC-G. CONCLUSIONS: The genetic association between ALS-G-PDC-G implicates TAU in the genetic susceptibility to ALS-G-PDC-G. TAU may be a modifying gene increasing risk for ALS-G-PDC-G in the presence of another, as yet, unidentified gene.
BACKGROUND: A Guam variant of amyotrophic lateral sclerosis (ALS-G) and parkinsonism dementia complex (PDC-G) are found in the Chamorro people of Guam. Both disorders have overlapping neuropathologic findings, with neurofibrillary tangles in spinal cord and brain. The cause of ALS-G-PDC-G is unknown, although inheritance and environment appear important. Because neurofibrillary tangles containing tau protein are present in ALS-G-PDC-G, and because mutations in the tau gene (TAU) cause autosomal dominant frontotemporal dementia, TAU was examined as a candidate gene for ALS-G-PDC-G. METHODS:TAU was evaluated by DNA sequence analysis in subjects with ALS-G-PDC-G, by linkage analysis of TAU polymorphisms in an extended pedigree from the village of Umatac, and by evaluation of linkage disequilibrium with polymorphic markers flanking and within TAU. RESULTS: Linkage disequilibrium between ALS-G-PDC-G and the TAU polymorphism CA3662 was observed. For this 2-allele system, PDC and ALS cases were significantly less likely than Guamanian controls to have the 1 allele (4.9% and 2% vs 11.5%, respectively; Fisher exact P =.007). DNA sequence analysis of TAU coding regions did not demonstrate a mutation responsible for ALS-G-PDC-G. Analysis of TAU genotypes in an extended pedigree of subjects from Umatac showed obligate recombinants between TAU and ALS-G-PDC-G. Linkage analysis of the Umatac pedigree indicates that TAU is not the major gene for ALS-G-PDC-G. CONCLUSIONS: The genetic association between ALS-G-PDC-G implicates TAU in the genetic susceptibility to ALS-G-PDC-G. TAU may be a modifying gene increasing risk for ALS-G-PDC-G in the presence of another, as yet, unidentified gene.
Authors: Wan Yang; Randall L Woltjer; Izabela Sokal; Catherine Pan; Yan Wang; Mary Brodey; Elaine R Peskind; James B Leverenz; Jing Zhang; Daniel P Perl; Douglas R Galasko; Thomas J Montine Journal: Am J Pathol Date: 2007-08-03 Impact factor: 4.307
Authors: Weiva Sieh; Yoonha Choi; Nicola H Chapman; Ulla-Katrina Craig; Ellen J Steinbart; Joseph H Rothstein; Kiyomitsu Oyanagi; Ralph M Garruto; Thomas D Bird; Douglas R Galasko; Gerard D Schellenberg; Ellen M Wijsman Journal: Hum Mol Genet Date: 2009-06-30 Impact factor: 6.150
Authors: Dana M Reiff; Rita Spathis; Chim W Chan; Miguel G Vilar; Krithivasan Sankaranarayanan; Daniel Lynch; Emily Ehrlich; Samantha Kerath; Risana Chowdhury; Leah Robinowitz; J Koji Lum; Ralph M Garruto Journal: Neurol Sci Date: 2011-08-06 Impact factor: 3.307
Authors: Mark S Forman; M Luise Schmidt; Sanjay Kasturi; Daniel P Perl; Virginia M-Y Lee; John Q Trojanowski Journal: Am J Pathol Date: 2002-05 Impact factor: 4.307
Authors: Mohammad Arif; Syed Faraz Kazim; Inge Grundke-Iqbal; Ralph M Garruto; Khalid Iqbal Journal: Proc Natl Acad Sci U S A Date: 2014-01-06 Impact factor: 11.205
Authors: Meredith C Hermosura; Hannah Nayakanti; Maxim V Dorovkov; Fernanda R Calderon; Alexey G Ryazanov; David S Haymer; Ralph M Garruto Journal: Proc Natl Acad Sci U S A Date: 2005-07-28 Impact factor: 11.205
Authors: Beth A Dombroski; Douglas R Galasko; Ignacio F Mata; Cyrus P Zabetian; Ulla-Katrina Craig; Ralph M Garruto; Kiyomitsu Oyanagi; Gerard D Schellenberg Journal: JAMA Neurol Date: 2013-06 Impact factor: 18.302
Authors: Jason M B Wilson; Iraj Khabazian; Margaret C Wong; Arash Seyedalikhani; Jaswinder S Bains; Bryce A Pasqualotto; David E Williams; Raymond J Andersen; Rebecca J Simpson; Richard Smith; Ulla-Kate Craig; Leonard T Kurland; Christopher A Shaw Journal: Neuromolecular Med Date: 2002 Impact factor: 3.843